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Abstract
Background: In hospitals, Clostridium difficile infection (CDI) surveillance relies on unvalidated guidelines or
threshold criteria to identify outbreaks. This can result in false-positive and -negative cluster alarms. The application
of statistical methods to identify and understand CDI clusters may be a useful alternative or complement to
standard surveillance techniques. The objectives of this study were to investigate the utility of the temporal scan
statistic for detecting CDI clusters and determine if there are significant differences in the rate of CDI cases by
month, season, and year in a community hospital.
Methods: Bacteriology reports of patients identified with a CDI from August 2006 to February 2011 were collected.
For patients detected with CDI from March 2010 to February 2011, stool specimens were obtained. Clostridium
difficile isolates were characterized by ribotyping and investigated for the presence of toxin genes by PCR. CDI
clusters were investigated using a retrospective temporal scan test statistic. Statistically significant clusters were
compared to known CDI outbreaks within the hospital. A negative binomial regression model was used to identify
associations between year, season, month and the rate of CDI cases.
Results: Overall, 86 CDI cases were identified. Eighteen specimens were analyzed and nine ribotypes were classified
with ribotype 027 (n = 6) the most prevalent. The temporal scan statistic identified significant CDI clusters at the
hospital (n = 5), service (n = 6), and ward (n = 4) levels (P ≤ 0.05). Three clusters were concordant with the one C.
difficile outbreak identified by hospital personnel. Two clusters were identified as potential outbreaks. The negative
binomial model indicated years 2007–2010 (P ≤ 0.05) had decreased CDI rates compared to 2006 and spring had
an increased CDI rate compared to the fall (P = 0.023).
Conclusions: Application of the temporal scan statistic identified several clusters, including potential outbreaks not
detected by hospital personnel. The identification of time periods with decreased or increased CDI rates may have
been a result of specific hospital events. Understanding the clustering of CDIs can aid in the interpretation of
surveillance data and lead to the development of better early detection systems.
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Background
Clostridium difficile represents a significant burden to
public health in terms of outbreaks, infection control mea-
sures, increased patient morbidity and mortality rates, and
patient costs [1]. Detection of C. difficile outbreaks in
healthcare settings may rely on rule-based or threshold
criteria; criteria that are prone to error as they fail to ad-
dress changes in population size or random variation [2].
The identification of a spurious disease cluster may result
in the waste of hospital resources due to investigational
procedures and/or interventions [2]. Conversely, a delay
in recognizing, or a failure to recognize, a true disease
cluster can inhibit the application of enhanced infection
control measures early in an outbreak, with the potential
to prolong the outbreak. Understanding the clustering of
infectious diseases, spatially and/or temporally, can be
used to identify risk factors [3], facilitate detailed investi-
gations to determine the association between exposures
and disease interventions [4], and detect outbreaks [5]. A
commonly used statistical technique to detect disease
clusters, the scan statistic has been employed to investi-
gate a wide array of infectious diseases or pathogens in-
cluding Shigella [6], malaria [7], meningococcal disease
[8], Escherichia coli 0157 [5], and listeriosis [9].
There has been limited incorporation of the scan stat-
istic for the detection and evaluation of spatial and/or
temporal disease clusters for hospital surveillance pur-
poses. Furthermore, no studies have been conducted in
community hospitals evaluating the effectiveness of the
temporal scan statistic, compared to traditional surveil-
lance techniques, for the detection and evaluation of C.
difficile clusters. Understanding the clustering of C. diffi-
cile infections (CDI) can aid in the interpretation of on-
going surveillance data, detect outbreaks at an earlier
time, and lead to new hypotheses regarding the trans-
mission of C. difficile within the hospital setting.
The objectives of this study were the following: to in-
vestigate the utility of the temporal scan statistic for de-
tecting CDI clusters in a community hospital and
validate statistically significant clusters using molecular
typing (i.e., ribotyping) and hospital records concerning
known CDI outbreaks; and to determine if there were
significant differences in the rate of CDI cases by month,
season, and year using regression models.
Methods
Study site
A single community hospital in southern Ontario, Canada
participated in this study. This facility has 345 beds and
over 200,000 in- and out-patient visits annually and pro-
vides a number of services including oncology, pediatrics,
intensive care, emergency, internal medicine, psychiatry,
rehabilitation, and surgery. This study was approved by
the research ethics boards of the University of Guelph and
the participating hospital.
Case definition
For this investigation, a case of CDI was defined as a patient
with new diarrhea and any of the following (WAC, personal
communication):
 Laboratory confirmation of a positive fecal toxin
assay for C. difficile; and/or
 Visualization of pseudomembranes on
sigmoidoscopy or colonoscopy; and/or
 Histological/pathological diagnosis of
pseudomembranous colitis.
Diarrhea was characterized as the following: three or
more bowel movements in 24 hours; loose/watery bowel
movements that conform to the shape of the specimen
container; and there is no other recognized etiology for
the diarrhea. Cases of CDI were classified as healthcare-
associated if the patient’s diarrhea developed > 48 hours
following hospital admission.
Data collection
For this longitudinal study, a case was included if C. diffi-
cile was identified between August 1, 2006 and February
28, 2011 and > 48 hours following hospital admission.
Only one CDI case per patient per admission-discharge
period was included in the analyses. The admission-
discharge period was defined as the interval from when a
patient was admitted to, and discharged from, the hospital.
Transfer to another ward was not considered a discharge.
For a patient to be admitted ≥ 2 times to the hospital,
> 24 hours between the discharge and admission dates
was required. Data from the first bacteriology report per
patient per admission-discharge period were obtained.
Bacteriology reports from CDI patients located in the
emergency and hemodialysis departments were excluded
as these departments specifically support outpatients.
For CDI cases identified between March 1, 2010 and
February 28, 2011, the hospital’s microbiology laboratory
collected and submitted stool specimens that were posi-
tive for C. difficile for molecular typing. In the participat-
ing hospital, C. difficile was identified by testing for the
C. difficile antigen, glutamate dehydrogenase, and toxins
A and B (C. Diff Quik Chek Complete, TechLab, Blacks-
burg, Virginia, USA). If a specimen was positive for the
C. difficile antigen, but toxin negative, a second test was
conducted to detect toxins A and B (ImmunoCard Toxins
A and B, Meridian Bioscience, Inc., Cincinnati, Ohio,
USA). This particular testing regimen was adopted by the
hospital’s microbiology laboratory, as an additional 5-10%
of specimens were identified as C. difficile by incorporat-
ing the second test (WAC, personal communication). At
Faires et al. BMC Infectious Diseases 2014, 14:254 Page 2 of 11
http://www.biomedcentral.com/1471-2334/14/254
the hospital level, all stool specimens submitted for C. difficile
testing were collected at the discretion of medical personnel.
Only one specimen per patient was collected for
molecular typing.
Information collected from the bacteriology report in-
cluded a unique patient identifier, dates pertaining to
when the patient was admitted and discharged, when a
stool specimen was collected for C. difficile testing, and
the ward location of the patient when the stool specimen
was collected. For ward location, bacteriology reports pro-
vided both service and ward designations. Services were
defined as specific departments (e.g., internal medicine,
surgery) whereas wards were characterized as specific,
physically distinct units that comprised a service (e.g., S1
and S2 wards comprised the surgery department).
Information regarding the number of patient days per
month for each service was collected. For wards, data on
patient days were obtained only from those wards that
were operational and provided the same service for the
entire study period (i.e., 55 months). For descriptive sta-
tistics, incidence rates for CDI were expressed as the
number of CDI cases per 10,000 patient days.
Data pertaining to known C. difficile outbreaks that oc-
curred during the study period (e.g., start and end date,
ward location, and number of patients involved) were col-
lected from the hospital’s Infection Prevention and
Control (IPC) department. Culture and molecular typing
were not performed as a clinical or infection control tool,
therefore historical typing data were not available. In the
participating hospital, outbreak notification thresholds for
C. difficile are employed and consist of the following [10]:
 For units with ≥ 20 beds: 3 cases of CDI identified
on one unit within a 7 day period or 5 cases within
a 4 week period. For units with < 20 beds: 2 cases of
CDI identified on one unit within a 7 day period or
4 cases within a 4 week period; or
 A baseline CDI rate for 2 months that is at or above
the 80th percentile for comparator hospitals; or
 A facility rate that is ≥ 2 standard deviations above
their baseline.
Processing of specimens
Patient stool specimens were obtained from the hospi-
tal’s microbiology laboratory following C. difficile con-
firmation and forwarded to the laboratory at the
University of Guelph on a weekly basis. Approximately 1
gm of feces was inoculated into 9 ml of brain-heart infu-
sion broth supplemented with 0.1% sodium taurocholate
and incubated, anaerobically, at 37°C for 5 days. A 2 ml
aliquot of broth was alcohol shocked by addition of an
equal volume of anhydrous alcohol and incubated at
room temperature for one hour followed by centrifuga-
tion at 4,000 rpm for 10 minutes. The resulting pellet
was inoculated onto C. difficile moxalactam-norfloxacin
agar (Oxoid, Nepean, Ontario, Canada) and incubated
anaerobically for 24–96 hours at 37°C. Presumptive col-
onies were sub-cultured onto blood agar (Oxoid, Nepean,
Ontario, Canada) and identified as C. difficile based on
characteristic morphology, odour, and production of L-
proline-aminopeptidase (Prodisk, Remel, Lenexa, Kansas,
USA). All C. difficile isolates were investigated for the
presence of genes for toxin A (tcdA) [11], toxin B (tcdB)
[12], and the binary toxin (cdtA) [13] using PCR. Ribotyp-
ing [14] was also performed on all C. difficile isolates.
When a ribotype pattern was known to be an inter-
national ribotype based on comparison to reference
strains, the appropriate numerical designation (e.g., 027)
was assigned. Otherwise, an internal laboratory designa-
tion was assigned.
Statistical analysis
All bacteriology reports were provided by the hospital in
electronic format. The temporal scan statistic was per-
formed using SaTScan version 9.0 [15] and all descrip-
tive statistics and model building were conducted using
Stata 11.0 (StataCorp LP, College Station, Texas, USA).
For all hypothesis tests, if not stated otherwise, a 5% sig-
nificance level was applied (α ≤ 0.05).
Temporal scan statistic to identify CDI clusters
To identify CDI clusters, the temporal scan statistic
employing a Poisson model was used. Currently, there are
no versions of the scan statistic that use the negative bino-
mial distribution for its likelihood ratio tests. However, it
should be noted that Poisson models are a special case of
negative binomial models which have an additional over-
dispersion parameter. In the case of the scan statistic, the
P-values of the test are based on Monte-Carlo hypothesis
testing rather than distributional assumptions. Conse-
quently, the P-values of the scan statistic are estimated
correctly without the addition of an overdispersion
parameter.
The scan statistic involves a flexible scanning window
that gradually moves across time. The number of ob-
served and expected observations inside the window is
compared to outside the window, at each time period,
with the greatest excess of observed cases noted [15,16].
Under the null hypothesis, the expected number of cases
in each time period covered by the scanning window is
proportional to its population size; whereas under the al-
ternative hypothesis, there is an elevated risk within the
window as compared to outside the window [15].The
window identified as least likely due to chance is subse-
quently evaluated by a maximum likelihood test with a
test decision based on a Monte-Carlo simulated P-value
[15]. For this analysis, Monte-Carlo replications were set
at 9999.
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To detect CDI clusters, only periods with high rates (i.e.,
a one-tailed test) were scanned. The maximum temporal
window size was set to 50% of the study period. In
addition, an adjustment for more likely clusters was made
by conducting an iterative scan statistic where the cluster
identified from the first iteration is removed from the data
set and a new analysis is performed using the remaining
data [15]. Data were analyzed on a monthly scale. A clus-
ter was defined as a period where the rate of CDI cases
was statistically higher than expected inside a window
compared to outside a window.
Retrospective monthly scan tests were conducted for
the entire study period (i.e., August, 2006 to February,
2011) as well as annually (January 1st – December 31st)
from 2006 to 2011. For 2006, the time interval was re-
stricted from August 1st – December 31st and for 2011,
the time interval was confined to January 1st – February
28th. For each time interval, temporal scan tests were con-
ducted to identify CDI clusters at three different levels in-
cluding hospital wide, service, and ward. For this analysis,
10 services were identified and included acute care, com-
plex care, hospice, the intensive care unit, internal medi-
cine, oncology, pediatrics, psychiatry, rehabilitation, and
surgery. Three wards were identified and included M1
(medicine), S1 (surgery), and S2 (surgery).
Significant (P ≤ 0.05) CDI clusters that were identified
by the temporal scan statistic were compared to out-
breaks identified by the IPC department. In addition,
CDI cases that comprised significant C. difficile clusters
were compared based on ribotype. Characteristics of sig-
nificant clusters (e.g., time frame, observed and expected
case numbers, P-value, and ribotype) are reported.
Statistical model for CDI rates
To evaluate the association between the rate of CDI
cases in the hospital and the independent variables year,
season, and month, a Poisson regression analysis was
conducted. For the exposure variable year, 2011 was re-
moved from the analysis as no CDI cases were identified
during that period. For season, months were categorized
in the following groupings: winter (January – March),
spring (April – June), summer (July – September), and
fall (October – December). The dependent variable was
the number of CDI cases and the offset was the natural
log of the population at risk (i.e., number of patient
days), for a particular month. Due to the hierarchical
structure of the data, CDI cases nested in wards, a
multilevel Poisson model including a random intercept
for ward and a fixed effect for service, was used to adjust
for clustering. The variable service was categorized as
medicine (intensive care, oncology, pediatrics, internal
medicine), surgery, and other (psychiatry, rehabilitation,
hospice, childbirth, nursery).
The Spearman’s rank correlation coefficient was used to
identify correlations between independent variables. Vari-
ables with a correlation above 0.8 were investigated for
collinearity and the biologically more plausible variable
was retained in the model [17]. Univariable multilevel
Poisson models were fit using marginal likelihood estima-
tion via the adaptive quadrature algorithm (as imple-
mented in the xtmepoisson procedure in Stata) to screen
each independent variable with the dependent variable
using a liberal significance level (α ≤ 0.20). Manual back-
wards step-wise modeling was applied to fit a multivari-
able multilevel Poisson model to all previously identified
significant co-variables. To assess the significance of the
independent variables, the likelihood ratio test was uti-
lized. Confounding was evaluated by examining the effect
of the removed variables on the coefficients of the
remaining variables. A variable was considered to be a
confounder if it changed the model coefficients by ≥ 20%
[18]. Interaction terms were examined for all independent
variables, with statistically significant main effects retained
in the model. Due to concerns regarding unexplained
overdispersion, the Poisson random effects model was
compared to a negative binomial random effects model
using Akaike’s Information Criteria (AIC). The random ef-
fects negative binomial model was used where the over-
dispersion parameter was allowed to vary randomly by
cluster based on a beta distribution (using the xtnbreg
command in Stata) [19]. The model with the lowest AIC
was selected. Based on the final multivariable model, con-
trasts for independent variables with >2 categories were




Over the study period, 86 CDI cases were identified, con-
tributing 5,499 patient-days. No patient was identified
with CDI for two or more hospital admission-discharge
periods. Forty-six (53.5%) cases were male and 40 (46.5%)
cases were female. For males, cases ranged in age from 21
to 95 years (median = 72 years) and for females, cases
ranged in age from 25 to 100 years (median = 76 years).
The monthly incidence rate of CDIs fluctuated over
the study period and ranged from 0 to 5.28 CDI cases/
10,000 patient days with an average of 1.14 CDI cases/
10,000 patient days (Figure 1). Based on the surveillance
data that were available, no CDI cases were identified in
the first two months of 2011. Summary characteristics of
the CDI incidence rate according to month, year, season,
service, and ward are presented in Table 1. The highest
incidence rate for CDI occurred in 2006, followed by
2007 and 2010. April and May had the highest incidence
rates, 1.66 and 1.59 CDI cases/10,000 patient days, re-
spectively. For season, spring was observed with the
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highest incidence rate for CDI and winter was observed
with the lowest. Services with the largest CDI incidence
rates included acute care, the intensive care unit, and in-
ternal medicine. No CDI cases were reported in the hos-
pice or pediatric wards.
From March 1, 2010 to February 28, 2011, 24 CDI
cases were identified and 18 (75%) C. difficile specimens
were collected for ribotyping (Table 2). Overall, nine dif-
ferent ribotypes were identified with ribotype 027
(33.3%) being the most prevalent. Nine (50%) of the C.
difficile isolates were identified with the gene for the bin-
ary toxin.
Temporal scan statistic to identify CDI clusters
Over the study period, the temporal scan statistic identi-
fied significant CDI clusters at the hospital (n = 5), ser-
vice (n = 6), and ward (n = 4) levels (Table 3). As
separate scan tests were conducted at various levels, it
was observed that several clusters overlapped in time
and/or location. Of the 15 clusters identified, only five
were classified as separate events.
Overall, clusters ranged in length from 2 to 14 months
in duration (median = 5 months) and involved a range of
3 to 44 CDI cases (median = 9 cases) per cluster. From
August 2006 to February 2011, IPC personnel identified
only one C. difficile outbreak which occurred during a
three-and-a-half week period during October and No-
vember of 2008. This outbreak was identified by three
scan tests applied at the hospital, service, and ward
levels (Cluster ID 4, 10, 13). However, for all three clus-
ters, the starting and end dates spanned from September
to October 2008, respectively.
For the remaining CDI clusters, overall, 7 (58.3%) were
considered to be of short duration (1–6 months in
length) and 5 (41.7%) were classified as long duration
(7–14 months in length). Investigation of the short dur-
ation cluster in ward M1 (Cluster ID 14) revealed that
three of the CDI cases were identified over a two day
period and therefore met one of the threshold criteria
for a possible C. difficile outbreak in this facility. As this
cluster was identified using historical data, molecular
data were not available for validation purposes.
Two clusters (Cluster ID 2, 6) were characterized
using typing data. For both clusters, analysis of C. diffi-
cile specimens identified several different ribotypes
present in the patient population. For the long duration,
hospital wide cluster (Cluster ID 2), further examination
of the six ribotype 027 cases revealed that three of the
cases were located in the same ward and were identified
with CDI over a 20 day period. Furthermore, two of the
ribotype 027 cases were identified on the same day,
therefore meeting one of the hospital’s threshold criteria
for a possible C. difficile outbreak. For the remaining
cluster with corresponding typing data (Cluster ID 6), all
four cases were identified with dissimilar ribotypes, and
these cases were not concordant with any of the hospi-
tal’s notification criteria. For all other clusters identified
by the temporal scan statistic, none met the notification
threshold criteria used by the study hospital.
Statistical model for CDI rates
A random effects negative binomial model was chosen
over the random effects Poisson model based on the
AIC value. Results of the univariable multilevel negative
binomial regression models indicated that year, season,
and month were significantly associated with the rate of
CDI cases (Table 4). For the final multivariable multi-
level negative binomial model, year and season were sig-
nificant independent variables (Table 5). The final model
indicated that the years 2007–2010 were significantly
Figure 1 Incidence rate of Clostridium difficile infection cases from August 1, 2006 to February 28, 2011.
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associated with a decreased incidence rate of CDI com-
pared to 2006 and that the rate of CDI cases was signifi-
cantly higher in the spring compared to the fall. Results
from significant model-based contrasts indicated an in-
crease in the incidence rate in CDI cases in the spring
compared to the winter, and in the years 2007 and 2010
compared to 2008 and 2009 (Table 6).
Discussion
In public health, the detection of outbreaks generally de-
pends on non-statistical methods, ad hoc analyses, or
unvalidated thresholds [6]. Furthermore, within the hos-
pital setting, rule-based criteria are often applied to as-
certain if an outbreak has occurred [2]. Consequently,
the above approaches may result in false outbreak
alarms or outbreaks that are overlooked, and subse-
quently the misuse of hospital resources or a missed op-
portunity for further case investigation [2] or prompt
intervention, prevention, and control. Therefore, studies
evaluating the incorporation of various statistical methods
to complement traditional surveillance techniques within
the hospital setting are being performed. For C. difficile,
research has been conducted to assess the effectiveness
of different statistical methods, including the Knox test
[20,21] and computer-assisted algorithms using micro-
biology data [22] to enhance surveillance in healthcare
facilities. The Knox test focuses on clustering in time
and space [20] and does not utilize a scanning window.
For the two studies incorporating this statistical tech-
nique, results were not compared to routine infection
control strategies for identifying C. difficile infections
within the hospital setting [20,21]. Furthermore, the
lack of patient specimens in one investigation precluded
the validation of C. difficile clusters at the molecular
level [21]. Although Rexach and colleagues [20] conducted
Table 1 Summary characteristics of 86 CDI cases, August
1, 2006 to February 28, 2011
CDI characteristics Incidence rate of CDI















2006 (August – December) 2.99
2007 (January – December) 1.58
2008 (January – December) 0.42
2009 (January – December) 0.47
2010 (January – December) 1.49
2011 (January – February) 0
Season1
Spring (April – June) 1.6
Summer (July – September) 1.4
Fall (October – December) 1.1
















CDI = Clostridium difficile infection.
1Incidence rate presented is based on an average for that specific period.
2Incidence rate presented is the total for that specific year.
3Incidence rate presented is the total for that service or ward from August 1,
2006 to February 28, 2011.
Table 2 Typing data for 18 Clostridium difficile patient
isolates, March 1, 2010 to February 28, 2011
Ribotype Number of Clostridium
difficile isolates (%)
Toxin genes
027 6 (33.3) tcdA, tcdB, cdtA
001 3 (16.7) tcdA, tcdB
V 2 (11.1) tcdA, tcdB
Y 2 (11.1) tcdA, tcdB, cdtA
AF 1 (5.6) tcdA, tcdB
T 1 (5.6) tcdA, tcdB
CMFA 1 (5.6) tcdA, tcdB
CMFB 1 (5.6) tcdA, tcdB
CMFC 1 (5.6) tcdA, tcdB, cdtA
tcdA = Toxin A.
tcdB = Toxin B.
cdtA = Binary toxin.
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fingerprint analysis on C. difficile isolates from a pediatric
patient population, the researchers observed that none
of the clusters based on molecular typing corresponded
to clusters identified by the Knox test. Through the cre-
ation of a monitoring system using microbiological data,
Hacek and colleagues [22] identified several suspected
outbreaks, of various pathogens, in a tertiary-care hos-
pital that were not detected by standard surveillance
techniques. However, a large majority of the suspected
outbreaks were not investigated using molecular typing.
The application of the scan statistic to detect C. diffi-
cile clusters has not been evaluated. The present study is
among the first investigations to assess the utility of the
temporal scan statistic for detecting C. difficile clusters
in a community hospital in addition to investigating
clusters using molecular techniques.
Table 3 Statistically significant temporal clusters of CDI rates, August 1, 2006 to February 28, 2011








1a 2006-20113 2006/8/1 – 2007/8/31 44 2.22 < 0.001 Not available







3c 20074 2007/4/1 – 2007/8/31 19 1.75 0.025 Not available
4d 20085 2008/9/1 – 2008/10/31 5 4.22 0.041 Not available
5 20094 2009/5/1 – 2009/9/30 8 2.39 0.006 Not available
Service scans
6b Complex care, 2010/4/1 – 2010/5/31 4 10.32 0.04 CMFA (1), CMFB (1), MOH-V (1), 001 (1)
2006-20114,6
7c Intensive care unit, 2007/6/1 – 2007/7/31 4 12.14 0.019 Not available
2006-20114, 7
8a Internal medicine, 2006/8/1 – 2007/8/31 18 2.82 < 0.001 Not available
2006-20113
9c Internal medicine, 20074 2007/4/1 – 2007/8/31 10 2.37 0.001 Not available
10d Internal medicine, 20085 2008/9/1 – 2008/10/31 3 5.78 0.026 Not available
11a Psychiatry, 2006/8/1 – 2007/9/30 9 4.23 < 0.001 Not available
2006-20113
Ward scans
12a M1, 2006-20113 2006/8/1 – 2007/8/31 14 3.41 < 0.001 Not available
13d M1, 2006-20115,8 2008/9/1 – 2008/10/31 3 15.17 0.017 Not available
14c M1, 20074 2007/4/1 – 2007/8/31 9 2.37 0.004 Not available
15a S1, 2006-20114 2006/11/1 – 2006/12/31 4 9.83 0.042 Not available
CDI = Clostridium difficile infection.
n = Number of isolates.
1Time period over which the scan was conducted.
2Month and year the significant cluster was identified by the temporal scan statistic.
3Long duration cluster (7–14 months in length).
4Short duration cluster (1–6 months in length).
5Cluster was part of the C. difficile outbreak identified by Infection Prevention and Control personnel.
6Cluster was also identified in the Complex care department for the 2010 annual analysis.
7Cluster was also identified in the Intensive care unit for the 2007 annual analysis.
8Cluster was also identified in M1 in the 2008 annual analysis.
a-dIndicates a cluster identified by >1 temporal scan.
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CDI clusters
In this investigation, a cluster was defined as a statistically
significant high rate of CDI cases within a time period.
The application of the temporal scan statistic to historical
hospital data resulted in the identification of 15 significant
clusters, five of which were separate events. By conducting
scan tests at the hospital, service, and ward levels, this
methodology allowed for the identification of clusters in
different departments and wards. Subsequently, investiga-
tions can be focused at various levels to identify specific
factors that may be associated with an increase in the rate
of CDI cases in addition to developing and evaluating
intervention and/or prevention measures.
Data from the hospital’s IPC department indicated that
during the study period, only one C. difficile outbreak was
identified by hospital personnel. Although this particular
outbreak was identified at three different levels (Cluster
ID 4, 10, 13) using the temporal scan statistic, the starting
date for the clusters was reported as September 2008, a
month earlier than the outbreak noted by IPC personnel.
This is an important finding as the outbreak may have
begun in September and therefore, case investigations and
institution of infection control measures to prevent trans-
mission events and environmental contamination with C.
difficile, could have been initiated earlier.
Ten clusters were identified between August 2006 and
February 2010, the retrospective study period; therefore,
molecular data were not available to validate these events.
Further examination of these 10 events revealed four clus-
ters that were considered to be of long duration and six
clusters considered to be of short duration. For the long
duration clusters (Cluster ID 1, 8, 11, 12), a significant
Table 4 Univariable regression analysis* of variables
associated with the rate of CDI cases
Variable Description IRR 95% CI P-value
Year 2006 Referent
2007 0.48 0.26 – 0.89 0.019
2008 0.13 0.05 – 0.32 < 0.001
2009 0.16 0.07 – 0.36 < 0.001
2010 0.49 0.27 – 0.90 0.022
Season Fall Referent
Winter 0.54 0.25 – 1.18 0.121
Spring 1.33 0.73 – 2.42 0.356
Summer 1.15 0.63 – 2.07 0.652
Month January Referent
February 4.19 0.47 – 37.55 0.200
March 4.76 0.54 – 41.95 0.160
April 7.52 0.89 – 62.97 0.063
May 8.70 1.09 – 69.11 0.041
June 7.55 0.92 – 61.69 0.059
July 6.36 0.75 – 53.59 0.089
August 6.19 0.77 – 50.00 0.087
September 7.95 1.01 – 62.47 0.049
October 5.01 0.59 – 41.95 0.137
November 6.90 0.86 – 55.33 0.069
December 6.11 0.76 – 49.29 0.089
Service Medicine1 Referent
Surgery 1.29 0.27 – 6.31 0.747
Other2 1.02 0.29 – 3.61 0.973
*Multilevel negative binomial regression model with a random intercept
for ward.
CDI = Clostridium difficile infection.
IRR = Incidence rate ratio.
CI = Confidence interval.
1Included the following departments: intensive care (adult and neonatal),
oncology, pediatrics, and internal medicine.
2Included the following departments: psychiatry, rehabilitation, hospice,
childbirth, and nursery.
Table 5 Multivariable regression model* of variables
associated with the rate of CDI cases
Variable Description IRR 95% CI P-value
Year 2006 Referent
2007 0.43 0.22 – 0.83 0.013
2008 0.11 0.04 – 0.29 < 0.001
2009 0.14 0.06 – 0.32 < 0.001
2010 0.43 0.22 – 0.83 0.012
Season Fall Referent
Winter 0.81 0.36 – 1.80 0.606
Spring 2.07 1.10 – 3.89 0.023
Summer 1.29 0.73 – 2.29 0.379
Service Medicine1 Referent
Surgery 1.15 0.20 – 6.53 0.871
Other2 0.74 0.18 – 2.95 0.667
*Multivariable multilevel negative binomial regression model with a random
intercept for ward.
CDI = Clostridium difficile infection.
IRR = Incidence rate ratio.
CI = Confidence interval.
1Included the following departments: intensive care (adult and neonatal),
oncology, pediatrics, and internal medicine.
2Included the following departments: psychiatry, rehabilitation, hospice,
childbirth, and nursery.
Table 6 Significant model-based contrasts between the
rate of CDI cases and year and season
Description IRR 95% CI P-value
2007 versus 2008 3.82 1.60 – 9.12 0.002
2007 versus 2009 3.15 1.39 – 7.08 0.006
2010 versus 2008 3.85 1.61 – 9.21 0.002
2010 versus 2009 3.17 1.42 – 7.08 0.005
Spring versus Winter 2.56 1.22 – 5.38 0.013
CDI = Clostridium difficile infection.
IRR = Incidence rate ratio.
CI = Confidence interval.
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increase in the rate of CDI cases were noted in the hos-
pital overall, which was attributed to increases in the rate
of CDI cases in two services (e.g., internal medicine and
psychiatry) and one ward that was located in the internal
medicine department. Although the exact biological rele-
vance of these long duration clusters is not known, plaus-
ible scenarios include extended outbreaks, temporal
trends, and the representation of systematic changes at
the hospital level during the surveillance period. Results
from the statistical analyses indicated that a significant in-
crease in the CDI incidence rate occurred during 2007 as
compared to 2008 and 2009, which was concordant with
the temporal scan statistic as all four long duration clus-
ters spanned 2007. The application of standardized report-
ing procedures for CDI in the province of Ontario is a
possible explanation for this finding. Commencing Sep-
tember 2008, hospitals located in Ontario were required
to collect and report monthly data on CDI to the Ontario
Ministry of Health and Long-term Care for posting on a
public accessible web site [23]. Daneman and colleagues
[24] assessed the change in hospital-specific rates of CDI
prior to and following the mandatory reporting period.
Before September 2008, the overall rates of CDI in On-
tario increased from 7.01 cases/10,000 patient days in
2002 to 10.79 cases/10,000 patient days in 2007. Following
September 2008, there was a 26.7% reduction in CDI rates
over the reporting period. This decrease in the CDI rate
may be attributable to hospitals strictly adhering to best
practices in C. difficile prevention due to the mandatory
reporting of rates to the public [24].
For short duration clusters (Cluster ID 3, 5, 7, 9, 14,
15), a significant hospital wide cluster in 2007 (Cluster
ID 3) was a result of an increase in the rate of CDI cases
in two services (e.g., the intensive care unit and internal
medicine) and a ward located in the internal medicine
department. Further examination of this particular clus-
ter revealed a potential C. difficile outbreak in this ward
that was not identified by IPC personnel. In addition, a
review of three other CDI cases that comprised this
ward cluster revealed that these three patients were
identified with CDI over a 20 day period. Although in-
vestigations of the remaining short duration clusters did
not reveal additional potential outbreaks consistent with
the hospital’s threshold criteria, overall, these clusters
should not be discounted as potential outbreaks on the
basis of not conforming to specific criteria. In the study
hospital, the threshold criteria used for detecting a CDI
outbreak are provided by the province’s Ministry of
Health and Long-Term Care [10]; however, as these
thresholds have not been validated, the criteria are sub-
jective guidelines.
In this investigation, two clusters were investigated
using molecular data. For the cluster observed in the com-
plex care service (Cluster ID 6), four CDI cases were
identified over a two month period, with three of the cases
specifically identified within a 16 day period. Molecular
typing of the C. difficile isolates established that each case
had a different ribotype. Based on these results, it is diffi-
cult to determine the biological relevance of this particular
cluster. Simply, this event may represent a coincidental
occurrence of CDI cases with different strains; however,
this cluster may also represent a potential outbreak or
possible transmission events. It has been previously re-
ported that different ribotypes may be present in a patient
population during a C. difficile outbreak [25]. Additionally,
transmission of C. difficile due to environmental contam-
ination or by unidentified patients, staff, or visitors in-
fected or colonized with C. difficile are also possible
scenarios. In one study investigating CDIs in healthcare
and community settings, 45% (428/957) of CDI cases were
genetically distinct from previous CDI cases indicating
that C. difficile was not transmitted from another symp-
tomatic patient but may have been acquired from asymp-
tomatic individuals or other reservoirs [26]. The second
cluster that was investigated with molecular data (Cluster
ID 2) contained 24 CDI cases which were identified hos-
pital wide over a 10 month period. Molecular typing of C.
difficile specimens from 18 cases identified nine different
ribotypes in this cluster, including ribotype 027. Further
examination of three of the ribotype 027 cases identified a
potential outbreak in a ward, based on the hospital’s
threshold criteria.
CDI rate
Results of the statistical analyses indicate that the inci-
dence rate for CDI was significantly higher in the spring
compared to the fall and winter seasons. The identifica-
tion of increased CDI rates in spring is in contrast to
previous studies that demonstrated an increase in the in-
cidence rate of CDI cases in the winter months [27-29].
However, in these investigations, data pertaining to sea-
son (e.g., what months reflected a particular season)
were not defined or analyses of specific individual sea-
sons (e.g., winter, spring, summer, fall) were not per-
formed. The higher incidence rates of CDI in the winter
months may be attributed to various determinants in-
cluding the presence of the influenza virus or respira-
tory syncytial virus in the hospital patient population
[27], the use of antimicrobials [30-32] especially in the
winter months due to respiratory viruses [29] and co-
morbidities or severe illness in patients admitted to the
hospital during winter months [29].
Model-based contrasts for the independent variable
year identified 2010 as being significantly associated with
an increase CDI incidence rate compared to years 2008
and 2009. This increased CDI rate in the hospital in
2010 may be attributable to the 2009–2010 H1N1 influ-
enza pandemic. As H1N1 cases were admitted to the
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participating hospital, it is possible that infections due to
C. difficile increased soon after as routine infection con-
trol strategies focused on H1N1 instead of C. difficile.
In this investigation, nine different ribotypes were iden-
tified in the patient population, with ribotypes 027 and
001 being the most prevalent. This is not surprising as
these two ribotypes have been identified as the most
prevalent among C. difficile isolates from Ontario diagnos-
tic laboratories [33]. Ribotype 027 has been responsible
for various outbreaks of CDI with increased severity, high
relapse rates, and significant mortality in Canada [34,35]
and internationally [36,37]. Overall, 50% of C. difficile iso-
lates in this study were identified containing the gene for
the binary toxin. The role of the binary toxin in the patho-
genesis of C. difficile is unclear.
In the present investigation, retrospective analyses of
microbiology data using a statistical technique were
promising in terms of identifying plausible C. difficile
clusters. However, there is a need for prospective studies
to identify statistical C. difficile clusters, assess the inci-
dence of false positive clusters, investigate the detection
of outbreaks at an earlier time, and evaluate how much
this form of quantitative surveillance supports and im-
proves traditional hospital surveillance methodologies.
This study has several limitations. Patient isolates were
only collected over one year and not all patient specimens
were available for typing. Therefore, the true molecular
composition of clusters, and the biological relevance of
several clusters, was unknown. Some of the clusters/tem-
poral patterns identified during this investigation could
represent shifts in patient demographics. However, patient
demographic data (i.e., sex, age) of the hospital population
were not available at the temporal resolution required for
our analyses. Furthermore, the number of C. difficile cases
included in the analysis was limited and the investigation
was conducted in only one community hospital. Conse-
quently, results may not be generalizable to other medical
facilities.
Conclusions
Epidemiological data containing a time reference can be
used to perform temporal analyses for the detection and
evaluation of CDI clusters. By understanding the cluster-
ing of CDIs in time, potential risk factors and/or out-
breaks may be identified. Furthermore, by incorporating
molecular typing data with epidemiological data, CDI
clusters can be further examined to better identify po-
tential outbreaks, prevent the misclassification of cases
as outbreak or non-outbreak, and elucidate transmission
events. In this investigation, the application of the tem-
poral scan statistic identified several significant CDI
clusters, two of which were potential outbreaks. Further-
more, significant increases in the incidence rate of CDI
cases in years 2007 and 2010 were concordant with the
findings from the temporal scan statistic as approxi-
mately 67% of the clusters identified spanned 2007 or
2010.
The application of the scan statistic to retrospective
microbiology and patient data can help enhance infec-
tion control activities in the hospital setting. For ex-
ample, at the study hospital, specific threshold criteria
are currently being used to determine if a C. difficile out-
break is occurring and subsequently, if an investigation
or response should be initiated. By employing a statis-
tical method for hospital surveillance, threshold criteria
may be created or re-defined for detecting C. difficile
outbreaks that are specific to a particular medical facil-
ity, service, or ward. In addition, the application of the
scan statistic, prospectively, may result in the identifica-
tion of a potential cluster or outbreak in a timely man-
ner. Subsequently, infection control activities may be
initiated earlier to prevent additional cases. Future stud-
ies examining the utility of the temporal scan statistic
for identifying CDI clusters under different settings (e.g.,
hospital type, length of investigation, retrospective and
prospective analyses) and comparing results to other
surveillance algorithms are required.
Abbreviations
CDI: Clostridium difficile infection; IPC: Infection prevention and control;
AIC: Akaike’s information criteria; tcdA: Toxin A; tcdB: Toxin B; cdtA: Binary
toxin; IRR: Incidence rate ratio; CI: Confidence interval; n: Number of isolates.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MCF contributed to study design, data collection, analysis, and drafting of
the manuscript. DLP and OB contributed to study design and statistical
analysis. WAC contributed to study design and data collection. JSW
contributed to study design and molecular analysis. RRS contributed to study
design. All authors contributed to the editing and final version of the
manuscript.
Acknowledgements
The authors wish to thank the hospital that participated in this study, the
Infection Prevention and Control Department personnel for research
assistance, the microbiology laboratory personnel for collecting patient
specimens, and Barbara Merry for coordinating laboratory data. We would
also like to thank Joyce Rousseau, Terri Lowe, and Meagan Walker for
assisting in C. difficile isolation and typing. The statistical infrastructure for
analyses was supported through a grant to D.L. Pearl from the Canada
Foundation for Innovation and the Ontario Research Fund.
Author details
1Department of Population Medicine, University of Guelph, Guelph, Ontario,
Canada. 2Infection Prevention and Control, Grand River Hospital, Kitchener,
Ontario, Canada. 3Department of Pathology and Molecular Medicine,
McMaster University, Hamilton, Ontario, Canada. 4Department of
Mathematics and Statistics, University of Guelph, Guelph, Ontario, Canada.
5Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada.
Received: 24 December 2013 Accepted: 30 April 2014
Published: 12 May 2014
Faires et al. BMC Infectious Diseases 2014, 14:254 Page 10 of 11
http://www.biomedcentral.com/1471-2334/14/254
References
1. Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P: Costs
of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008,
70:15–20.
2. Huang SS, Yokoe DS, Stelling J, Placzek H, Kulldorff M, Kleinman K, O’Brien
TF, Calderwood MS, Vostok J, Dunn J, Platt R: Automated detection of
infectious disease outbreaks in hospitals: a retrospective cohort study.
PLoS Med 2010, 7:e1000238.
3. Torabi M, Rosychuk RJ: An examination of five spatial disease clustering
methodologies for the identification of childhood cancer clusters in
Alberta, Canada. Spat Spatiotemporal Epidemiol 2011, 2:321–330.
4. Jennings JM, Curriero FC, Celentano D, Ellen JM: Geographic identification
of high gonorrhea transmission areas in Baltimore, Maryland.
Am J Epidemiol 2005, 161:73–80.
5. Pearl DL, Louie M, Chui L, Doré K, Grimsrud KM, Leedell D, Martin SW,
Michel P, Svenson LW, McEwen SA: The use of outbreak information in
the interpretation of clustering of reported cases of Escherichia coli 0157
in space and time in Alberta, Canada, 2000–2002. Epidemiol Infect 2006,
134:699–711.
6. Stelling J, Yih WK, Galas M, Kulldorff M, Pichel M, Terragno R, Tuduri E,
Espetxe S, Binsztein N, O’Brien TF, Platt R, Collaborative Group
WHONET-Argentina: Automated use of WHONET and SaTScan to detect
outbreaks of Shigella spp. using antimicrobial resistance phenotypes.
Epidemiol Infect 2010, 138:873–883.
7. Coleman M, Coleman M, Mabuza AM, Kok G, Coetzee M, Durrheim DN:
Using the SaTScan method to detect local malaria clusters for guiding
malaria control programmes. Malar J 2009, 8:68.
8. Elias J, Harmsen D, Claus H, Hellenbrand W, Frosch M, Vogel U:
Spatiotemporal analysis of invasive meningococcal disease, Germany.
Emerg Infect Dis 2006, 12:1689–1695.
9. Sauders BD, Fortes ED, Morse DL, Dumas N, Kiehlbauch JA, Schukken Y,
Hibbs JR, Wiedmann M: Molecular subtyping to detect human listeriosis
clusters. Emerg Infect Dis 2003, 9:672–680.
10. Ontario Agency for Health Protection and Promotion, Provincial Infectious
Diseases Advisory Committee. [http://www.publichealthontario.ca/en/eRepository/
PIDAC-IPC_Annex_C_Testing_SurveillanceManage_C_difficile_2013.pdf]
11. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K,
Kim SM, Chong Y, Wasito EB: Identification of toxin A-negative, toxin B-
positive Clostridium difficile by PCR. J Clin Microbiol 1998, 36:2178–2182.
12. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, Pons
JL: Multiplex PCR targeting tpi (triose phosphate isomerise), tcdA (Toxin
A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
J Clin Microbiol 2004, 42:5710–5714.
13. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M: Production of
actin-specific ADP-ribosyltransferase (binary toxin) by strains of
Clostridium difficile. FEMS Microbiol Lett 2000, 186:307–312.
14. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC: Development of a new
PCR-ribotyping method for Clostridium difficile based on ribosomal RNA
gene sequencing. FEMS Microbiol Lett 1999, 175:261–266.
15. SaTScan software for the spatial and space-time scan statistic.
[http://www.satscan.org/]
16. Kulldorff M, Heffernan R, Hartman J, Assunção R, Mostashari F: A space-time
permutation scan statistic for disease outbreak detection. PLoS Med 2005,
2:e59.
17. Dohoo IR, Martin W, Stryhn H: Model-building strategies. In Methods in
Epidemiologic Research. Charlottetown, Prince Edward Island: AVC, Inc;
2012:401–428.
18. Dohoo IR, Martin W, Stryhn H: Confounding: Detection and Control. In
Methods in Epidemiologic Research. Charlottetown, Prince Edward Island:
AVC, Inc; 2012:307–358.
19. StataCorp: xtnbreg. In Stata 10 Base Reference Manual. College Station,
Texas: Stata Press; 2007:317–327.
20. Rexach CE, Tang-Feldman YJ, Cohen SH: Spatial and temporal analysis of
Clostridium difficile infection in patients at a pediatric hospital in
California. Infect Control Hosp Epidemiol 2005, 26:691–696.
21. Kroker PB, Bower M, Azadian B: Clostridium difficile infection, hospital
geography and time-space clustering. QJM 2001, 94:223–225.
22. Hacek DM, Cordell RL, Noskin GA, Peterson LR: Computer-assisted
surveillance for detecting clonal outbreaks of nosocomial infection.
J Clin Microbiol 2004, 42:1170–1175.
23. Health Quality Ontario. [http://www.hqontario.ca/public-reporting/patient-
safety/information-about-patient-safety-quality-indicators]
24. Daneman N, Stukel TA, Ma X, Vermeulen M, Guttmann A: Reduction in
Clostridium difficile infection rates after mandatory hospital public
reporting: findings from a longitudinal cohort study in Canada. PLoS Med
2012, 7:e1001268.
25. Aldeyab MA, Devine MJ, Flanagan P, Mannion M, Craig A, Scott MG,
Harbarth S, Vernaz N, Davies E, Brazier JS, Smyth B, McElnay JC, Gilmore BF,
Conlon G, Magee FA, Elhajji FW, Small S, Edwards C, Funston C, Kearney MP:
Multihospital outbreak of Clostridium difficile ribotype 027 infection:
epidemiology and analysis of control measures. Infect Control Hosp
Epidemiol 2011, 32:210–219.
26. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, Ip CL,
Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R,
Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TE, Walker AS: Diverse
sources of C. difficile infection identified on whole-genome sequencing.
N Engl J Med 2013, 369:1195–1205.
27. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M: Seasonal variations in
Clostridium difficile infections are associated with influenza and
respiratory syncytial virus activity independently of antibiotic
prescriptions: a time series analysis in Québec, Canada. Antimicrob Agents
Chemother 2012, 56:639–646.
28. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M: Epidemiological patterns
and hospital characteristics associated with increased incidence of
Clostridium difficile infection in Quebec, Canada, 1998–2006. Infect Control
Hosp Epidemiol 2010, 31:939–947.
29. Archibald LK, Banerjee SN, Jarvis WR: Secular trends in hospital-acquired
Clostridium difficile disease in the United States, 1987–2001. J Infect Dis
2004, 189:1585–1589.
30. Labbé AC, Poirier L, Maccannell D, Louie T, Savoie M, Béliveau C, Laverdière
M, Pépin J: Clostridium difficile infections in a Canadian tertiary care
hospital before and during a regional epidemic associated with the BI/
NAP1/027 strain. Antimicrob Agents Chemother 2008, 52:3180–3187.
31. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol
SP, Johnson S, Gerding DN: An epidemic, toxin gene-variant strain of
Clostridium difficile. N Engl J Med 2005, 353:2433–2441.
32. Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM:
Hospital-wide restriction of clindamycin: effect on the incidence of
Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998,
128:989–995.
33. Martin H, Willey B, Low DE, Staempfli HR, McGeer A, Boerlin P, Mulvey M,
Weese JS: Characterization of Clostridium difficile strains isolated from
patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol 2008,
46:2999–3004.
34. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault
AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K,
Hudson TJ, Horn R, René P, Monczak Y, Dascal A: A predominantly clonal
multi-institutional outbreak of Clostridium difficile-associated diarrhea
with high morbidity and mortality. N Engl J Med 2005, 353:2442–2449.
35. Pépin J, Valiquette L, Cossette B: Mortality attributable to nosocomial
Clostridium difficile–associated disease during an epidemic caused by a
hypervirulent strain in Quebec. CMAJ 2005, 173:1037–1042.
36. Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A,
van der Kooi T, van den Hof S, Notermans DW: Clostridium difficile ribotype
027, toxinotype III, the Netherlands. Emerg Infect Dis 2006, 12:827–830.
37. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E,
McDonald LC: Toxin production by an emerging strain of Clostridium
difficile associated with outbreaks of severe disease in North America
and Europe. Lancet 2005, 366:1079–1084.
doi:10.1186/1471-2334-14-254
Cite this article as: Faires et al.: Detection of Clostridium difficile infection
clusters, using the temporal scan statistic, in a community hospital in
southern Ontario, Canada, 2006–2011. BMC Infectious Diseases
2014 14:254.
Faires et al. BMC Infectious Diseases 2014, 14:254 Page 11 of 11
http://www.biomedcentral.com/1471-2334/14/254
